Munetake Kanda

478 total citations
14 papers, 354 citations indexed

About

Munetake Kanda is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Munetake Kanda has authored 14 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 5 papers in Molecular Biology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Munetake Kanda's work include Blood Pressure and Hypertension Studies (2 papers), Cardiac Ischemia and Reperfusion (2 papers) and Pulmonary Hypertension Research and Treatments (2 papers). Munetake Kanda is often cited by papers focused on Blood Pressure and Hypertension Studies (2 papers), Cardiac Ischemia and Reperfusion (2 papers) and Pulmonary Hypertension Research and Treatments (2 papers). Munetake Kanda collaborates with scholars based in Japan and United States. Munetake Kanda's co-authors include Noritoshi Nagaya, Wataru Shimizu, Satoshi Yasuda, Shunichi Miyazaki, Yoichi Goto, Hiroshi Nonogi, Shiro Kamakura, Kazuhiro Suyama, Kiyotaka Matsuo and Takashi Kurita and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Munetake Kanda

13 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Munetake Kanda Japan 8 181 166 53 45 41 14 354
En Takashi Japan 7 150 0.8× 157 0.9× 35 0.7× 64 1.4× 34 0.8× 10 460
Ines Pagel Germany 11 207 1.1× 264 1.6× 56 1.1× 31 0.7× 28 0.7× 14 452
Junzo Osaki Japan 9 160 0.9× 188 1.1× 32 0.6× 93 2.1× 29 0.7× 11 357
Siyong Teng China 11 227 1.3× 207 1.2× 28 0.5× 46 1.0× 34 0.8× 26 394
Danielle M. Trappanese United States 11 174 1.0× 150 0.9× 43 0.8× 54 1.2× 19 0.5× 14 380
Birgit E.J. Teunissen Netherlands 9 366 2.0× 227 1.4× 82 1.5× 49 1.1× 22 0.5× 10 529
Ben Ma United States 11 150 0.8× 101 0.6× 60 1.1× 28 0.6× 19 0.5× 20 327
Koh‐ichiro Kinugawa Japan 10 165 0.9× 127 0.8× 106 2.0× 40 0.9× 21 0.5× 14 357
Hrag Esfahani Belgium 10 196 1.1× 120 0.7× 63 1.2× 48 1.1× 12 0.3× 20 343
Steve T. Yeh United States 9 224 1.2× 108 0.7× 41 0.8× 29 0.6× 18 0.4× 18 384

Countries citing papers authored by Munetake Kanda

Since Specialization
Citations

This map shows the geographic impact of Munetake Kanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Munetake Kanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Munetake Kanda more than expected).

Fields of papers citing papers by Munetake Kanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Munetake Kanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Munetake Kanda. The network helps show where Munetake Kanda may publish in the future.

Co-authorship network of co-authors of Munetake Kanda

This figure shows the co-authorship network connecting the top 25 collaborators of Munetake Kanda. A scholar is included among the top collaborators of Munetake Kanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Munetake Kanda. Munetake Kanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kawano, Hiroaki, Koichi Kawamura, Munetake Kanda, et al.. (2021). Histopathological changes of myocytes in restrictive cardiomyopathy. Medical Molecular Morphology. 54(3). 289–295. 3 indexed citations
2.
Kanda, Munetake, Yoshito Ihara, Hiroaki Murata, et al.. (2006). Glutaredoxin Modulates Platelet-derived Growth Factor-dependent Cell Signaling by Regulating the Redox Status of Low Molecular Weight Protein-tyrosine Phosphatase. Journal of Biological Chemistry. 281(39). 28518–28528. 51 indexed citations
4.
Yasuda, Satoshi, Shunichi Miyazaki, Hideyuki Kinoshita, et al.. (2006). Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction. Clinical Science. 112(1). 43–49. 34 indexed citations
5.
Qiu, Huiying, Yoshihiro Fujimori, Keisuke Nishioka, et al.. (2006). Postnatal neovascularization by endothelial progenitor cells immortalized with the simian virus 40T antigen gene. International Journal of Oncology. 28(4). 815–21. 6 indexed citations
6.
Kawano, Hiroaki, Takahiro Hayashida, Hiroshi Ohtani, et al.. (2005). Histopathological Findings of the No-reflow Phenomenon Following Coronary Intervention for Acute Coronary Syndrome. International Heart Journal. 46(2). 327–332. 18 indexed citations
7.
Nagaya, N, T. Horio, Kunio Miyatake, et al.. (2004). Cell therapy for pulmonary hypertension: What is the true potential of endothelial progenitor cells? Response. Circulation. 109(12). 2 indexed citations
8.
Ihara, Yoshito, Shino Manabe, Munetake Kanda, et al.. (2004). Increased expression of protein C-mannosylation in the aortic vessels of diabetic Zucker rats. Glycobiology. 15(4). 383–392. 28 indexed citations
9.
Nagaya, Noritoshi, Mikiyasu Shirai, Etsuro Tanaka, et al.. (2004). Adrenomedullin gene transfer induces therapeutic angiogenesis in a rabbit model of chronic hind limb ischemia: benefits of a novel nonviral vector, gelatin.. PubMed. 109(4). 526–31. 59 indexed citations
10.
Nagaya, Noritoshi, Mikiyasu Shirai, Etsuro Tanaka, et al.. (2004). Adrenomedullin Gene Transfer Induces Therapeutic Angiogenesis in a Rabbit Model of Chronic Hind Limb Ischemia. Circulation. 109(4). 526–531. 2 indexed citations
11.
Nagaya, Noritoshi, Munetake Kanda, Masaaki Uematsu, et al.. (2003). Hybrid Cell–Gene Therapy for Pulmonary Hypertension Based on Phagocytosing Action of Endothelial Progenitor Cells. Circulation. 108(7). 889–895.
12.
Kanda, Munetake, Wataru Shimizu, Kiyotaka Matsuo, et al.. (2002). Electrophysiologic characteristics andimplications of induced ventricular fibrillationin symptomatic patients with brugada syndrome. Journal of the American College of Cardiology. 39(11). 1799–1805. 91 indexed citations
13.
Harano, Yutaka, et al.. (2002). Multifactorial insulin resistance and clinical impact in hypertension and cardiovascular diseases. Journal of Diabetes and its Complications. 16(1). 19–23. 14 indexed citations
14.
Kanda, Munetake, Satoshi Yasuda, Yoichi Goto, et al.. (1999). Diuretic effect of phosphodiesterase inhibitors depends on baseline renal function in patients with cogestive heart failure. The American Journal of Cardiology. 83(8). 1274–1277. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026